Rise Advisors’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-623
Closed -$25.7K – 552
2025
Q3
$25.7K Hold
623
– – 0.01% 444
2025
Q2
$27.5K Hold
623
– – 0.01% 378
2025
Q1
$23K Sell
623
-566
-48% -$20.2K 0.01% 432
2024
Q4
$39.6K Hold
1,189
– – 0.02% 290
2024
Q3
$30.9K Hold
1,189
– – 0.01% 400
2024
Q2
$26.7K Hold
1,189
– – 0.01% 432
2024
Q1
$28.2K Buy
+1,189
New +$26.4K 0.02% 410

Other funds holding EXEL

Rise Advisors's EXEL Position: Q4 2025 in Review

Rise Advisors sold out of Exelixis (EXEL) in Q4 2025, closing a stake of 623 shares — an estimated $25.7K sold.

Rise Advisors first reported a position in EXEL in Q1 2024 and held it in 7 quarters. The position peaked at $39.6K in Q4 2024. 685 funds tracked by Wall St. Rank hold EXEL as of Q4 2025.

  • Rise Advisors reported no remaining Exelixis position as of Q4 2025 after selling out during the quarter.
  • Rise Advisors sold 623 Exelixis shares in Q4 2025, an estimated $25.7K.
  • Rise Advisors first reported a position in Exelixis in Q1 2024 and held it in 7 quarters.
  • Rise Advisors's Exelixis position peaked at $39.6K in Q4 2024.
  • 685 funds tracked by Wall St. Rank held Exelixis as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.